Yang Mingxiao, Sun Mingsheng, Du Ting, Long Hulin, Chen Ji, Liang Fanrong, Lao Lixing
School of Chinese Medicine, University of Hong Kong, China.
Department of Chinese Medicine, University of Hong Kong-Shenzhen Hospital, China.
Eur J Prev Cardiol. 2021 Oct 25;28(13):1415-1425. doi: 10.1177/2047487319876761.
The aim of this study was to assess the efficacy and safety of acupuncture in the treatment of patients with stable angina pectoris.
A literature search was performed in nine databases, including PubMed and the Cochrane Library, from their inception to 30 August 2018. Randomized controlled trials that compared acupuncture therapy with sham acupuncture or no treatment were included. Two reviewers under the guidance of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines assessed the eligibility of each record and extracted essential information independently. The data were merged using a fixed-effect model.
Pooled analysis of 17 eligible trials with 1516 participants showed that acupuncture was associated with reduced angina attack frequency (-4.91; 95% confidence interval, -6.01- -3.82; p < 0.00001) and improved depression (-1.23; 95% confidence interval, -1.47- -1.00; p < 0.00001) and anxiety level (-0.96; 95% confidence interval, -1.16- -0.75; p < 0.00001) relative to sham treatment or standard care alone. No increased risk of adverse events was observed during treatment (relative risk, 0.70; 95% confidence interval, 0.33-1.48; p = 0.35). No significant improvement was shown in nitroglycerin use or angina intensity. The included studies were associated with unclear to high risk of selection or performance bias, and the quality of evidence was low to moderate.
Acupuncture may safely and effectively improve physical restrictions, emotional distress, and attack frequency in patients with stable angina pectoris. However, angina intensity and medication use were not reduced. Studies with adequate blinding and a valid sham control group are still warranted due to the current low quality of evidence.
本研究旨在评估针刺治疗稳定型心绞痛患者的疗效和安全性。
在包括PubMed和Cochrane图书馆在内的9个数据库中进行文献检索,检索时间从各数据库建立至2018年8月30日。纳入比较针刺疗法与假针刺或不治疗的随机对照试验。两名评审员在系统评价和Meta分析的首选报告项目指南指导下,独立评估每条记录的合格性并提取基本信息。数据采用固定效应模型合并。
对17项符合条件的试验(1516名参与者)进行的汇总分析表明,与假治疗或单纯标准护理相比,针刺可降低心绞痛发作频率(-4.91;95%置信区间,-6.01至-3.82;p < 0.00001),改善抑郁(-1.23;95%置信区间,-1.47至-1.00;p < 0.00001)和焦虑水平(-0.96;95%置信区间,-1.16至-0.75;p < 0.00001)。治疗期间未观察到不良事件风险增加(相对风险,0.70;95%置信区间,0.33至1.48;p = 0.35)。硝酸甘油使用或心绞痛强度未显示出显著改善。纳入的研究存在选择或实施偏倚的风险不明确至高风险,证据质量低至中等。
针刺可能安全有效地改善稳定型心绞痛患者的身体限制、情绪困扰和发作频率。然而心绞痛强度和药物使用并未减少。由于目前证据质量较低,仍需要进行充分盲法和有效假对照组的研究。